Pinnacle Wealth Management Advisory Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $247K | Sell |
608
-87
| -13% | -$35.3K | 0.02% | 328 |
|
2025
Q1 | $346K | Sell |
695
-133
| -16% | -$66.2K | 0.03% | 263 |
|
2024
Q4 | $431K | Sell |
828
-203
| -20% | -$106K | 0.04% | 223 |
|
2024
Q3 | $638K | Sell |
1,031
-92
| -8% | -$56.9K | 0.06% | 170 |
|
2024
Q2 | $621K | Buy |
1,123
+109
| +11% | +$60.3K | 0.06% | 170 |
|
2024
Q1 | $589K | Buy |
1,014
+496
| +96% | +$288K | 0.06% | 173 |
|
2023
Q4 | $275K | Sell |
518
-520
| -50% | -$276K | 0.03% | 266 |
|
2023
Q3 | $525K | Sell |
1,038
-160
| -13% | -$81K | 0.07% | 168 |
|
2023
Q2 | $625K | Sell |
1,198
-262
| -18% | -$137K | 0.08% | 158 |
|
2023
Q1 | $842K | Buy |
1,460
+160
| +12% | +$92.2K | 0.11% | 129 |
|
2022
Q4 | $716K | Buy |
1,300
+248
| +24% | +$137K | 0.11% | 137 |
|
2022
Q3 | $534K | Buy |
1,052
+522
| +98% | +$265K | 0.09% | 152 |
|
2022
Q2 | $288K | Buy |
530
+135
| +34% | +$73.4K | 0.05% | 227 |
|
2022
Q1 | $233K | Buy |
+395
| New | +$233K | 0.03% | 257 |
|